Literature DB >> 25166885

Mesenchymal stem cell-based angiotensin-converting enzyme 2 in treatment of acute lung injury rat induced by bleomycin.

Fengying Gao1, Qian Li, Lili Hou, Zhuozhe Li, Fang Min, Zhenwei Liu.   

Abstract

BACKGROUND: Acute lung injury (ALI) is a high incidence disease with no effective therapeutic method (mortality rate > 40%). The aim of this study was to find a new and effective therapeutic method for ALI.
METHODS: After the isolation of human umbilical cord mesenchymal stem cells (HUMSCs) from cesarean fetus, we transfected the HUMSCs with Lenti-ACE2 (angiotensin-converting enzyme 2) viral particles. Then we evaluated the therapeutic effect of HUMSCs harboring ACE2 on ALI, which induced by bleomycin (BLM) in rat model.
RESULTS: Our results showed that HUMSCs harboring ACE2 could attenuate ALI degree through reducing pulmonary inflammatory infiltration and degree of vascular permeability, repressing the mRNA level of pro-inflammatory cytokines, activating the mRNA level of anti-inflammatory cytokines and ACE2. Besides, results also demonstrated that HUMSCs harboring ACE2 gene had higher therapeutic effects to ALI than the single factor of HUMSCs or ACE2.
CONCLUSIONS: This research provided clues for the development of effective therapeutic methods to ALI using stem cell transplantation and gene therapy.

Entities:  

Keywords:  effective therapeutic method; pulmonary inflammatory infiltration; respiratory

Mesh:

Substances:

Year:  2014        PMID: 25166885     DOI: 10.3109/01902148.2014.938200

Source DB:  PubMed          Journal:  Exp Lung Res        ISSN: 0190-2148            Impact factor:   2.459


  5 in total

Review 1.  Mesenchymal Stromal Cells in Animal Bleomycin Pulmonary Fibrosis Models: A Systematic Review.

Authors:  Nadim Srour; Bernard Thébaud
Journal:  Stem Cells Transl Med       Date:  2015-10-22       Impact factor: 6.940

2.  Biological effects of bone marrow mesenchymal stem cells on hepatitis B virus in vitro.

Authors:  Wei-Ping Zheng; Bo-Ya Zhang; Zhong-Yang Shen; Ming-Li Yin; Yi Cao; Hong-Li Song
Journal:  Mol Med Rep       Date:  2017-03-15       Impact factor: 2.952

3.  Mesenchymal Stem Cells Overexpressing ACE2 Favorably Ameliorate LPS-Induced Inflammatory Injury in Mammary Epithelial Cells.

Authors:  Shuping Yan; Pingsheng Ye; Muhammad Tahir Aleem; Xi Chen; Nana Xie; Yuanshu Zhang
Journal:  Front Immunol       Date:  2022-01-14       Impact factor: 7.561

Review 4.  Mesenchymal Stem Cells for the Treatment of Idiopathic Pulmonary Fibrosis.

Authors:  Argyrios Tzouvelekis; Rebecca Toonkel; Theodoros Karampitsakos; Kantha Medapalli; Ioanna Ninou; Vasilis Aidinis; Demosthenes Bouros; Marilyn K Glassberg
Journal:  Front Med (Lausanne)       Date:  2018-05-15

5.  Lipoxin A4 attenuates LPS-induced acute lung injury via activation of the ACE2-Ang-(1-7)-Mas axis.

Authors:  Qiong-Feng Chen; Xiao-Dong Kuang; Qi-Feng Yuan; Hua Hao; Ting Zhang; Yong-Hong Huang; Xiao-Yan Zhou
Journal:  Innate Immun       Date:  2018-07-03       Impact factor: 2.680

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.